1例使用霉酚酸酯和利妥昔单抗成功治疗但未使用糖皮质激素的抗合成酶综合征病例。
A Case of Anti-Synthetase Syndrome Successfully Treated with Mycophenolate Mofetil and Rituximab but No Corticosteroids.
作者信息
Sieradzka Agnieszka Ewa, Naccini Bruno, Fontana Massimiliano
机构信息
Private Practice, Riva San Vitale, Ticino, Switzerland.
Pneumology Service, Ospedale Beata Vergine, Mendrisio, Ticino, Switzerland.
出版信息
Eur J Case Rep Intern Med. 2022 Jul 18;9(7):003324. doi: 10.12890/2022_003324. eCollection 2022.
UNLABELLED
A patient with antisynthetase syndrome with pulmonary and muscular involvement was treated with immunosuppressive agents without corticosteroids. Rituximab was added to mycophenolate mofetil therapy with improvement in lung functional and imaging findings and normalization of creatine kinase levels.
LEARNING POINTS
Antisynthetase syndrome associated with interstitial lung disease (ILD) and myopathy can be successfully treated without corticosteroids.A combination of several immunosuppressive agents can be a therapeutic alternative in case of refractory ILD.
未标注
一名患有抗合成酶综合征且伴有肺部和肌肉受累的患者接受了无皮质类固醇的免疫抑制剂治疗。在霉酚酸酯治疗中加用了利妥昔单抗，肺功能和影像学表现得到改善，肌酸激酶水平恢复正常。
学习要点
与间质性肺病（ILD）和肌病相关的抗合成酶综合征无需使用皮质类固醇即可成功治疗。对于难治性ILD，几种免疫抑制剂联合使用可能是一种治疗选择。
Zotero 插件